학술논문
Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
2219679X